Echo Therapeutics, Inc. specializes in creating transdermal skin permeation and diagnostic medical devices. Their offerings primarily target the wearable health consumer market and individuals with diabetes requiring outpatient care. The company is currently advancing a cutting-edge, needle-free, wireless Continuous Glucose Monitoring (CGM) system, specifically tailored for hospital settings across the European Union.